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Abstract 
Background: The ideal nomenclature of atopic dermatitis (AD) / atopic eczema (AE) 
has long been contested. However, it is becoming increasingly clear that the dis- 
parate nomenclature of this disease may have important deleterious ramifications 
for clinical care and research. 
Materials and Methods: An electronic questionnaire regarding the preferred 
nomenclature for AD was sent to councilors of the International Eczema Council 
(IEC) (n=77), an international group of clinicians and researchers with expertise in 
AD/AE. The survey consisted of 2 questions for consensus regarding the preference 
for an atopic prefix, and preference for the term AD or AE, and an exploratory 
question about the acceptability of the terms AD, AE or eczema. Consensus was 
defined a priori as at least 90% agreement for each question with a response rate 
of at least 90%. 
Results: Seventy-one of 77 (92.2%) IEC councilors and associates responded to the 
survey, with all respondents completing the entire survey. Consensus was reached 
for question 1, with 69 of 71 respondents (97.2%) preferring the atopic prefix. 
However, consensus was not reached for question 2, with 40 respondents (58.0%) 
preferring the term AD and 30 (43,5%) preferring AE. Sixty-three respondents 
(88.7%) and 55 (77.5%) felt that the terms AD and AE were acceptable, whereas 
only 11 (15.5%) felt that eczema was acceptable. 
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1   |  INTRODUCTION  
 
Atopic dermatitis and atopic eczema (AD and AE) are terms that 
describe a common, clinically defined, pruritic, inflammatory skin 
condition, characterized by a chronic and relapsing dermatitis in typi- 
cal anatomical sites. The ideal nomenclature of AD/AE has long been 
contested. However, it is becoming increasingly clear that the dis- 
parate nomenclature of this disease may have important deleterious 
ramifications for clinical care and research. 
 
1.1 | Historical aspects of AD/AE nomenclature 
The criteria and terms used to denote AD/AE were recently reviewed.1 
The term “eczema” (Greek for boiling) was introduced to the medical lit- 
erature by Robert Wilan (1757-1812) as a subgroup of the vesicular (or 
bullous) disorders and represents a description of primary lesions 
instead of a disease or etiology. Recurrent and often passionate discus- 
sions about the exact definition of eczema have occurred for cen- 
turies.2 
The “Oxford History of English” postulates that the term “dermati- 
tis” was first included in the Oxford English Dictionary only in 1876.3 
Other names used for AD at that time included “porrigo larvalis,” 
“lichen agrius,” and “prurigo Besnier”. Atopic eczema (AE) was first 
used by Abraham Walzer (1883-1965) in 1928.2 In 1933, Sulzberger 
and Wise first coined “atopic dermatitis” as a footnote in the “1933 
Year Book of Dermatology and Syphilology”. 
The term “atopic” was included in the terminology as it emerged 
that some individuals with AD/AE reacted on the skin to allergens. Fur- 
ther, the term “atopy” (Greek for “out of place”) was introduced by Coca 
and Cooke in 1923 as part of a new definition on hypersensitivities, cat- 
egorized with abnormal immunological patterns. However, the defini- 
tion of the term atopy is controversial. Some decades ago, atopy was 
defined by the associated diseases, as an “inheritable tendency to 
develop the atopic diseases, namely hay fever, bronchial asthma, and 
atopic dermatitis.” Presently, the World Allergy Organization defines 
atopy as “a personal and/or familial tendency, usually in childhood or 
adolescence, to become sensitized and produce Immunoglobulin E anti- 
bodies in response to ordinary exposure to allergens, usually proteins.” 
Given the lack of a clear definition, some prefer to exclude the term 
“atopy” and use “eczema” as the standalone disease nomenclature. 
A major question has been whether dermatitis, eczema, and 
other terminology represent the same entity. A pioneering descrip- 
tion of AD/AE or “constitutional prurigo” was provided by Hebra as 
 
a chronic, recurrent skin disorder, characterized by intensely pruritic 
papules and nodules on the trunk and limbs.4 Later, it was accepted 
that infantile eczema and neurodermatitis/diathetic prurigo in chil- 
dren and adults represented the same disease. During the second 
half of the twentieth century, the term “constitutional eczema” was 
preferred by French dermatologists, “neurodermatitis” by German- 
speaking dermatologists, and “atopic eczema” by British dermatolo- 
gists.4 Presently, many use the terms dermatitis, AD, and eczema syn- 
onymously, whereas others use the term eczema as a clinical 
description of the morphology of AD/AE lesions, which encompasses 
the acute, subacute, and chronic ill-defined lesions present in 
AD/AE. 
A recent consensus statement by the International League of 
Dermatological Societies, however, did not recognize eczema as an 
official morphological term.5 The disparate nomenclature used for 
AD/AE might introduce confusion and bias in reporting, as reviewed 
below. Hence, there is a need for a common nomenclature when 
discussing disease entities such as AD/AE. 
 
 
1.2 | Recent trends in the use of terminology 
Some interesting trends of terminology have emerged for AD over 
the past few decades as shown in a recent review article.6 Publica- 
tions using any of the different terms for AD/AE increased over 
the past 60 years,6 reflecting a combination of the increasing AD/ 
AE prevalence worldwide,7–9 the growing interest in the clinical 
features and scientific basis of AD/AE, and increases in resources, 
technologies, and the ability for scientific communication interna- 
tionally. The use of the terms “atopic dermatitis” and “atopic 
eczema” particularly increased in the late 1970s, coinciding with 
discussion of the seminal classification for AD/AE at the Interna- 
tional Symposium of Atopic Dermatitis in Oslo in 1979, followed 
by the publication of the Hanifin and Rajka criteria for AD/AE.10 
Publications using the term AD continue to increase annually, while 
publications using AE have slightly decreased annually between 
2008 and 2015. 
 
1.3 | Current use of terminology 
1.3.1 |  Scientific literature 
Of the many terms used for AD/AE in the scientific literature 
(Table 1), a recent systematic review and meta-analysis found that 
Conclusions: The IEC noted that the term eczema is imprecise, and its use is con- 
fusing. The consensus of the IEC was to recommend use of the prefix “atopic” (i.e., 
AD or AE) in all publications, presentations and discussions about the disorder. 
 
KE Y  W OR D  S 
atopic dermatitis, atopic eczema, nomenclature, terminology, consensus 
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TABL E 1 Different terms used for AD in the scientific literature 
Atopic dermatitis 
Atopic eczema 
Atopic neurodermatitis 
Atopiform dermatitis 
Besnier’s prurigo 
Childhood eczema 
Dermatitis 
Eczema 
Flexural eczema 
Infantile eczema 
Lichen agrius 
Neurodermatitis 
Porrigo larvalis 
 
 
“atopic dermatitis” and “eczema” were the most common.6 In MED- 
LINE (PubMed), 64.4% of publications addressing AD/AE used the 
term “atopic dermatitis,” 46.9% “eczema” and only 7.5% “atopic 
eczema.” Few publications used the terminology “childhood eczema,” 
“flexural eczema,” “infantile eczema,” “atopic neurodermatitis,” or 
“Besnier’s prurigo.” AD was also the most frequently used term in 
studies of adults and children, humans and animals, males and 
females, followed by “eczema” alone. AD was the most commonly 
used term in the highest impact-factor dermatology and allergy/im- 
munology journals, whereas “eczema” was the most commonly used 
term in the pediatric and internal medicine literature. “Atopic 
eczema” was the least commonly used of the three terms in all of 
these subgroups. It is imperative that harmonization of the nomen- 
clature for AD includes the many different specialties that manage 
AD and the broader healthcare provider community. 
There appear to be regional differences with respect to the pre- 
ferred terminology. AD was the most commonly used term in publi- 
cations written in English, Japanese, Spanish,6 and Korean 
(unpublished data), whereas “eczema” was most often used in publi- 
cations written in French, German, Italian, and Russian. “Atopic 
eczema” was the least commonly used of the three terms in all of 
these languages. These regional differences underscore the impera- 
tive for international consensus on AD nomenclature. 
 
1.3.2 | Lay population 
“Eczema” is the dominant terminology used by the lay population.11 
A recent study found that “eczema” and its common misspellings 
accounted for 84% of combined monthly searches on the Google, 
Bing, Yahoo, and Baidu Internet search engines.11 AD and AE 
accounted for only 14% and 2% of searches, respectively. Again, 
there appeared to be considerable regional differences in the popu- 
larity of terminology. “Eczema” was the most popular terminology 
searched for in English, Russian, Turkish, and Japanese, and “atopic 
eczema” was the least popular of the three terms by far. Consistent 
with this trend, the patient organizations for AD/AE in the USA and 
 
UK are titled the National Eczema Association and National Eczema 
Society, respectively, and even the International Eczema Council was 
so named to be understood by the lay public. 
 
1.3.3 | Clinical terminology 
Disparate terms are also used for AD/AE in the clinical setting, 
which has a number of important and potentially problematic ramifi- 
cations. Many clinicians treat the term “eczema” as a morphological 
descriptor for characteristic cutaneous lesions and histologic alter- 
ations in biopsy sections; this is the approach of the American Acad- 
emy of Dermatology.12 Others would use the term “spongiotic 
dermatitis” to describe the same histologic pattern. In fact, this use 
of “eczema” includes multiple morphologies, ranging from the acute, 
subacute, and chronic ill-defined lesions present in AD/AE. More- 
over, this use of “eczema” is far broader than the initial intent of the 
term in its original use for acute vesicular or bullous lesions. 
The term “atopic dermatitis” may be more appropriate, as it frames 
the multiple disease morphologies with a specific attribution to an 
atopic phenotype or etiology. On the other hand, many clinicians 
may use the term “eczema” as a synonym for AD/AE as per the lay 
public and/or the consensus of the World Allergy Organization.13 
The World Allergy Organizations proposed that the term eczema 
should replace the use of terms AD and AE and that AE should refer 
to eczema in a person of the atopic constitution.13 These recom- 
mendations have not been widely followed. The disparate use of ter- 
minology may be confusing for both clinicians and patients alike. 
 
1.3.4 | International classification of disease codes 
Importantly, the terms “atopic dermatitis” and “eczema” are associ- 
ated with different International Classification of Disease (ICD) codes 
(ICD-9: 691.8 vs 692.9; ICD-10: L20.x vs L30.9, respectively). How- 
ever, the ICD-9 code 692.9 is meant to be used for unspecified con- 
tact dermatitis; the ICD-10 code L30.9 is meant to be used even 
more broadly for unspecified dermatitis. Thus, when providers type 
the term “eczema” into an electronic health record, the software 
may apply incorrect ICD codes. The incorrect use of ICD billing 
codes might result in lack of reimbursement for certain medications 
and/or services by payers. 
The incorrect use of ICD codes also has major ramifications for 
epidemiology and health services research of AD/AE. A recent study 
examined the validity of the ICD-9 codes 691.8 (AD) and 692.9 
(eczema).14 Both codes were commonly used in AD/AE patients, 
with similar proportions of patients meeting Hanifin and Rajka crite- 
ria10 and United Kingdom Working Party Criteria15 for AD/AE. Ironi- 
cally, multiple occurrences of the eczema codes were associated 
with higher specificity (44.9% vs 23.8%, respectively) and positive 
predictive value (33.7% vs 29.9%) than multiple occurrences of the 
AD/AE codes. However, the eczema code also included higher rates 
of contact dermatitis, hand, asteatotic and dyshidrotic eczema, and 
unspecified rash. This imprecision in coding of AD/AE introduces 
bias and misclassification error. It is imperative that clinicians  be 
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more precise in their AD/AE coding. Proper education about correct 
use of terminology and ICD coding is warranted during medical edu- 
cation and residency training in dermatology and other specialties. 
This situation might be improved with the new ICD-11 classification 
system now being elaborated.16 
 
1.4 | Rationale for consensus 
Given the disparate use of different terms for AD/AE and the 
adverse consequences of this practice, there is an urgent and 
rational need for harmonized nomenclature for this condition. A sin- 
gle, universally applied name for AD/AE would enable better com- 
parison of the pathophysiology, epidemiology, comorbidities, and 
socioeconomic burden worldwide. It would also avoid further confu- 
sion related to a dichotomous view of AD/AE and eczema in some 
countries, such as China. 
As drug development is increasingly planned and implemented 
on a global level, a harmonized denomination would avoid a confu- 
sion in the assessment of medicines, medical devices, and diagnostic 
tests. The recruitment of patients for clinical trials requires a clear 
and consensual nomenclature in order to assure a consistent pheno- 
type across sites and regions. Consistent nomenclature of AD/AE is 
necessary prior to possible stratifications based on clinical pheno- 
types and/or biomarkers. The wording is of paramount importance 
when defining the indications of emerging therapies and formulating 
a summary of product characteristics. 
Moreover, harmonization of nomenclature would improve the 
study of AD/AE epidemiology and health services research, as well 
as the interpretation of research by physicians, consumers, and 
patients, alike. The advantages of the harmonization are obvious in 
the context of communicating knowledge between the global stake- 
holders of AD/AE. Last, and possibly most importantly, patients 
today independently collect information from many resources and 
need an exact diagnosis to avoid confusion as well as inappropriate 
guidance and therapy. 
The survey consisted of three questions: (1) Do you prefer the 
use of the atopic prefix (i.e., atopic eczema or atopic dermatitis) 
or the broader terms eczema or dermatitis? (2) If you answered yes 
to question 1, do you prefer the term atopic dermatitis or atopic 
eczema? Our a priori definition of consensus for questions 1 and 2 
was at least 90% agreement for each question with a response rate 
of at least 90%. An additional exploratory question was asked, but 
was not considered for consensus: (3) Regardless of the outcome of 
this survey, which of the following terms would be acceptable to 
you (atopic dermatitis/atopic eczema/eczema)? 
 
 
3 |  RESULTS 
 
Seventy-one of 77 (92.2%) IEC councilors and associates responded to 
the survey, with all respondents completing the entire survey. Respon- 
dents were from institutions in Australia,1 Austria,1 Brazil,1 Canada,4 
China,1 Denmark,3 France,6 Germany,12 India,1 Ireland,2 Israel,2 Italy,2 
Japan,4 Korea,2 the Netherlands,3 Spain,1 Taiwan,1 Tanzania,2 UK,5 and 
USA.17 Consensus was reached on for question 1, with 69 of 71 respon- 
dents (97.2%) preferring the atopic prefix (Table 2). Consensus was not 
reached for question 2, with 40 respondents (58.0%) preferring the 
term atopic dermatitis, 30 (43,5%) preferring atopic eczema, and 1 
(1.4%) invalid response. Sixty-three respondents (88.7%) and 55 
(77.5%) felt that the terms AD and AE were acceptable, whereas only 
11 (15.5%) felt that eczema was acceptable. 
 
 
4 |  DISCUSSION 
 
Among a large international group of clinicians and researchers with 
expertise in AD, we reached consensus on the requirement of an 
TABL E 2 Survey responses 
 
 
2   |  METHODS  
 
The IEC (http://www.eczemacouncil.org/), founded in 2014, is a 
global nonprofit organization whose membership consists of 77 AD 
experts from 21 countries on six continents. All councilors and 
associates are vetted for expertise in the field of AD, including 
research track record. IEC councilors gathered at the American 
Academy of Dermatology annual meeting in Washington, D.C. in 
2016 to review the disparate nomenclature of AD and related chal- 
lenges. Each topic was discussed by the group, and a team of coun- 
cilors subsequently reviewed the recent literature to write about 
the use of terminology for AD in the: i) scientific literature, ii) lay 
public, and iii) clinical setting. In March 2017, an electronic ques- 
tionnaire was sent to the IEC membership regarding their preferred 
nomenclature for AD. Study data were collected and managed using 
Microsoft Excel. 
(1) Do you prefer the use of 
the atopic prefix (i.e., atopic 
eczema or atopic dermatitis) 
or the broader terms eczema 
or dermatitis? 
 
 
 
(2) If you answered yes to 
question 1, do you prefer 
the term atopic dermatitis 
or atopic eczema? 
 
 
 
(3) Regardless of the outcome 
of this survey, which of the 
following terms would be 
acceptable to you (atopic 
dermatitis/atopic eczema/ 
eczema)? 
69 (97.2%) 2 (2.8%) 
 
 
 
 
 
 
 
40 (58.0%) 30 (43.5%) 
 
 
 
 
 
 
63 (88.7%) 55 (77.5%)  11 (15.5%) 
Question 
Responses 
Yes No 
Atopic Atopic Eczema 
dermatitis eczema 
Atopic Atopic 
dermatitis  eczema 
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atopic disease prefix, that is, AD or AE. Thus, the consensus of the 
IEC is to recommend against the use of the term “eczema” owing to 
its imprecision, and disparate and confusing real-world use. We were 
unable to reach consensus for preferred use of the term “atopic der- 
matitis” vs “atopic eczema,” although AD was more commonly pre- 
ferred and had the highest rate of acceptability. Our 
recommendation is to standardize the disease nomenclature with 
use of the terms “atopic dermatitis” or “atopic eczema” in clinical tri- 
als, scientific literature, presentations, and patient education. 
The consensus to not use the term “eczema” has important rami- 
fications for patient education. “Eczema” is the most common lay 
term for AD/AE. Currently, clinical history taking and survey-based 
research studies for AD/AE require use of the term “eczema.” Indeed, 
a recent multicenter validation study found that self- or caregiver- 
reported “eczema or skin allergy” had good sensitivity and positive 
predictive value.17 On the other hand, there are several etiologies of 
eczematous reactions, and patients may mistakenly assume that they 
have AD/AE when, in fact, they may have another form of eczema, 
such as stasis or nummular eczema or contact eczema. Thus, patient 
counseling for AD/AE must strike a balance between use of familiar 
lay terminology “eczema” and educating patients about their specific 
etiology of disease. We therefore recommend that the term “atopic” 
should be introduced to patients with AD/AE, rather than just sharing 
the diagnostic terms “eczema” or “dermatitis.” 
The transformation to consistency will not be an easy one. The 
term “eczema” is shorter and easier to use in conversation with 
patients (although more difficult to spell), and a shift to AD or AE 
would require patient discussions to clarify the imprecision of the 
term “eczema.” It may also be difficult for an organization focused 
on AD that includes “eczema” in its title to change its name to sup- 
port this unification, especially until a widespread movement is 
underway to shift to public utilization of the terms “atopic dermati- 
tis” or “atopic eczema.” Nevertheless, there is a solid rationale and 
partial consensus for a more precise name for this disorder by at 
least using the atopic prefix prior to the terms eczema or dermatitis. 
We encourage physicians in all specialties and in every country to 
shift their own use of terminology away from eczema alone to AD 
or AE in writing, presentations, and discussions with patients and 
other healthcare personnel as a first step. 
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